Annual D&A
$1.17 M
-$155.00 K-11.71%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual depreciation & amortization is currently $1.17 million, with the most recent change of -$155.00 thousand (-11.71%) on 31 December 2023. During the last 3 years, it has risen by +$627.00 thousand (+115.68%). PRLD annual D&A is now -11.71% below its all-time high of $1.32 million, reached on 31 December 2022.PRLD Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$405.00 K
-$47.00 K-10.40%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly depreciation & amortization is currently $405.00 thousand, with the most recent change of -$47.00 thousand (-10.40%) on 30 September 2024. Over the past year, it has increased by +$126.00 thousand (+45.16%). PRLD quarterly D&A is now -10.40% below its all-time high of $452.00 thousand, reached on 30 June 2024.PRLD Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.61 M
+$126.00 K+8.47%
30 September 2024
Summary:
Prelude Therapeutics Incorporated TTM depreciation & amortization is currently $1.61 million, with the most recent change of +$126.00 thousand (+8.47%) on 30 September 2024. Over the past year, it has increased by +$414.00 thousand (+34.50%). PRLD TTM D&A is now at all-time high.PRLD TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.7% | +45.2% | +34.5% |
| 3 y3 years | +115.7% | +52.3% | +112.9% |
| 5 y5 years | +684.6% | - | - |
PRLD Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.7% | +115.7% | -10.4% | +52.3% | at high | +112.9% |
| 5 y | 5 years | -11.7% | +684.6% | -10.4% | +206.8% | at high | +1122.7% |
| alltime | all time | -11.7% | +684.6% | -10.4% | +206.8% | at high | +1122.7% |
Prelude Therapeutics Incorporated Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $405.00 K(-10.4%) | $1.61 M(+8.5%) |
| June 2024 | - | $452.00 K(+6.1%) | $1.49 M(+13.0%) |
| Mar 2024 | - | $426.00 K(+28.7%) | $1.32 M(+12.7%) |
| Dec 2023 | $1.17 M(-11.7%) | $331.00 K(+18.6%) | $1.17 M(-2.6%) |
| Sept 2023 | - | $279.00 K(-0.7%) | $1.20 M(-4.6%) |
| June 2023 | - | $281.00 K(+1.1%) | $1.26 M(-2.9%) |
| Mar 2023 | - | $278.00 K(-23.2%) | $1.29 M(-2.2%) |
| Dec 2022 | $1.32 M | $362.00 K(+7.4%) | $1.32 M(+5.8%) |
| Sept 2022 | - | $337.00 K(+6.0%) | $1.25 M(+6.0%) |
| June 2022 | - | $318.00 K(+3.6%) | $1.18 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $307.00 K(+5.9%) | $1.06 M(+16.1%) |
| Dec 2021 | $915.00 K(+68.8%) | $290.00 K(+9.0%) | $915.00 K(+20.7%) |
| Sept 2021 | - | $266.00 K(+33.7%) | $758.00 K(+19.6%) |
| June 2021 | - | $199.00 K(+24.4%) | $634.00 K(+11.2%) |
| Mar 2021 | - | $160.00 K(+20.3%) | $570.00 K(+5.2%) |
| Dec 2020 | $542.00 K(+41.9%) | $133.00 K(-6.3%) | $542.00 K(+32.5%) |
| Sept 2020 | - | $142.00 K(+5.2%) | $409.00 K(+53.2%) |
| June 2020 | - | $135.00 K(+2.3%) | $267.00 K(+102.3%) |
| Mar 2020 | - | $132.00 K | $132.00 K |
| Dec 2019 | $382.00 K(+156.4%) | - | - |
| Dec 2018 | $149.00 K | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual D&A year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly D&A year-on-year change?
- What is Prelude Therapeutics Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM D&A year-on-year change?
What is Prelude Therapeutics Incorporated annual depreciation & amortization?
The current annual D&A of PRLD is $1.17 M
What is the all time high annual D&A for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual depreciation & amortization is $1.32 M
What is Prelude Therapeutics Incorporated annual D&A year-on-year change?
Over the past year, PRLD annual depreciation & amortization has changed by -$155.00 K (-11.71%)
What is Prelude Therapeutics Incorporated quarterly depreciation & amortization?
The current quarterly D&A of PRLD is $405.00 K
What is the all time high quarterly D&A for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly depreciation & amortization is $452.00 K
What is Prelude Therapeutics Incorporated quarterly D&A year-on-year change?
Over the past year, PRLD quarterly depreciation & amortization has changed by +$126.00 K (+45.16%)
What is Prelude Therapeutics Incorporated TTM depreciation & amortization?
The current TTM D&A of PRLD is $1.61 M
What is the all time high TTM D&A for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM depreciation & amortization is $1.61 M
What is Prelude Therapeutics Incorporated TTM D&A year-on-year change?
Over the past year, PRLD TTM depreciation & amortization has changed by +$414.00 K (+34.50%)